Where does Kush M Parmar work?

Kush M Parmar is Managing Partner at 5AM Ventures and Board director at Akouos and Board director at Entrada Therapeutics, Inc. and Board director at Homology Medicines.

What does Kush M Parmar invest in?

Kush M Parmar invests in Biotech, Healthtech, Medical Devices.

What check size does Kush M Parmar write?

Kush M Parmar typically writes checks of $100K – $5M.

What boards does Kush M Parmar sit on?

Kush M Parmar holds tracked board seats at Akouos, Ensoma, Entrada Therapeutics, Inc., Rallybio, LLC.

Where did Kush M Parmar go to school?

Kush M Parmar studied at Harvard Medical School (MD); Harvard Business School (Finance); Massachusetts Institute of Technology (M.D., HST Program).

Kush M Parmar

Investor

Managing Partner at 5AM Ventures · Board director at Akouos · Board director at Entrada Therapeutics, Inc. · Board director at Homology Medicines

Boston, Massachusetts

Writes $100K – $5M checks · typically $1.5M

About

Kush Parmar combines a Harvard M.D./Ph.D.-backed technical rigor with a cross‑border US–India perspective, taking hands‑on roles as co‑founder, chair, or senior executive to build globally relevant biotech, including India-focused initiatives.

Contact· self-published, not guessed

k•••@5amventures.comreveal

Likely emails· guessed from name + firm domain, not firm-published

k•••@5amventures.comreveal100% confident
k•••@5amventures.comreveal75% confident

Invests in

BiotechHealthtechMedical Devices

Board director at Akouos

Intro paths

→

In turn, Kush can intro founders to Akouos's investors below.

Akouos's investors · 8

5AM VenturesBoston · $100K – $4M checks · since 2018 Cowen Healthcare InvestmentsNew York EcoR1 CapitalSan Francisco Fidelity InvestmentsBoston New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks · since 2017 Pivotal Life SciencesSan Francisco RA CapitalBoston Sofinnova VenturesMenlo Park · $100K – $15M checks

Co-founders at Akouos

Emmanuel SimonsExecutive Officer, Director

william sewellFounder

Board director at Entrada Therapeutics, Inc.

Intro paths

→

In turn, Kush can intro founders to Entrada Therapeutics, Inc.'s investors below.

Entrada Therapeutics, Inc.'s investors · 5

5AM VenturesBoston · $100K – $4M checks · since 2021 Agent CapitalWaltham MPM BioImpactBoston · $1M – $15M checks · since 2021 Roche Venture FundBasel · $648K – $3.2M checks TCG CrossoverPalo Alto

Board director at Homology Medicines

Intro paths

→

In turn, Kush can intro founders to Homology Medicines's investors below.

Homology Medicines's investors · 11

5AM VenturesBoston · $100K – $4M checks · since 2017 AlexandriaPasadena ARCH Venture PartnersChicago · $50K – $250M checks · since 2017 Deerfield Management CompanyNew York · since 2017 HBM Healthcare InvestmentsZug Maverick VenturesSan Francisco · $3M – $10M checks OUP (Osage University Partners)Bala Cynwyd · $1M – $20M checks Rock Springs CapitalBaltimore TemasekSingapore · since 2017 Vida VenturesLos Angeles Vivo CapitalPalo Alto · $10M – $50M checks

Experience

5AM VenturesManaging Partnercurrent2010 — presentBoston, MA
ProLynxChairmancurrent2025 — present
Entrada TherapeuticsChairman Of The Board Of Directorscurrent2016 — present
EnsomaBoard Membercurrent2019 — presentBoston, Massachusetts, United States
Immuneel Therapeutics, Ltd.Co-Foundercurrent2019 — presentBangalore, India
Penn Medicine, University of Pennsylvania Health SystemResearch Council Membercurrent2018 — present
Princeton UniversityAdvisory Council, Department of Molecular Biologycurrent2015 — presentPrinceton, NJ
Audentes TherapeuticsBoard Of Directorscurrent2013 — present
Grace Science FoundationMember, Scientific Advisory Board2014 — 2025www.gracescience.org
Homology Medicines, Inc.Founding CEO, Chairman2015 — 2023Boston, Massachusetts
Vor BiopharmaChairman2019 — 2022
AkouosBoard Of Directors2017 — 2022Greater Boston
ArvinasBoard of Directors2013 — 2019
scPharmaceuticalsBoard of Directors2014 — 2018
Novira TherapeuticsBoard Observer and Acting VP, Strategy and Corporate Development2012 — 2015
AchaogenBoard Observer2010 — 2014
Society of Kauffman FellowsKauffman Fellow, Class 162011 — 2013
Envoy Therapeutics, Inc.Board Observer2010 — 2012
Cruz Blanca InitiativeFounder, President2000 — 2010

Skills & more

Lifesciences29Start-ups12Drug Discovery43Corporate Development13Strategy28Cancer4Oncology9Venture Capital57Clinical Development6Entrepreneurship16Business Development8Commercialization9

+6 more

Life SciencesPharmaceutical IndustryPrivate EquityBiotechnologyCellTechnology Transfer

From Kush's professional profile.

Deals · 2

Entrada Therapeutics, Inc.Board seat

via 5AM Ventures · filed Apr 2021 · $116.2M raise

AkouosBoard seat

via 5AM Ventures · filed Aug 2018 · $50.1M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Ensoma Rallybio, LLC

Per SEC Form D filings.

Colleagues at 5AM Ventures

Alex Wareham

Management Company Controller at 5AM Ventures

Andy Schwab

Managing Partner at 5AM Ventures

Aniqa Tasnim

Senior Associate at 5AM Ventures

Anna Yaeger

Chief Investment Officer and Partner at 5AM Ventures

Arthur Tzianabos

Venture Partner at 5AM Ventures

Bella Nittolo

Administrative Assistant and Office Manager at 5AM Ventures

Brian Daniels

Venture Partner at 5AM Ventures

Caroline Chamales

Senior Executive Assistant at 5AM Ventures

Frequently asked questions

Who is Kush M Parmar?: Kush Parmar combines a Harvard M.D./Ph.D.-backed technical rigor with a cross‑border US–India perspective, taking hands‑on roles as co‑founder, chair, or senior executive to build globally relevant biotech, including India-focused initiatives.
Where does Kush M Parmar work?: Kush M Parmar is Managing Partner at 5AM Ventures and Board director at Akouos and Board director at Entrada Therapeutics, Inc. and Board director at Homology Medicines.
What does Kush M Parmar invest in?: Kush M Parmar invests in Biotech, Healthtech, Medical Devices.
What check size does Kush M Parmar write?: Kush M Parmar typically writes checks of $100K – $5M.
What boards does Kush M Parmar sit on?: Kush M Parmar holds tracked board seats at Akouos, Ensoma, Entrada Therapeutics, Inc., Rallybio, LLC.
Where did Kush M Parmar go to school?: Kush M Parmar studied at Harvard Medical School (MD); Harvard Business School (Finance); Massachusetts Institute of Technology (M.D., HST Program).

Founder mafias

Massachusetts Institute of Technology mafia546

Also came through, then founded or led a company.

Elad GilPhDFounded Brain Co.Nat FriedmanBachelor of ScienceFounded Xamarin Matt HuangB.S.Founded Hotspots Delian AsparouhovDropoutFounded Nightingale +1 Drew HoustonBSFounded Dropbox +1 Arash FerdowsiComputer ScienceFounded Dropbox

+ 539 more

Harvard Business School mafia323

Also came through, then founded or led a company.

Mike Maples JrMBAFounded Pattern Breakers Hristo BorisovOPM Class 64Founded Payhawk Noubar AfeyanVisiting LecturerFounded ProFound Therapeutics +12 Wade MyersMBAFounded RealManage +5 Harry GrunerFounded Hilos +2 Ellen RubinMBAFounded ClearSky Data +2

+ 316 more

Princeton University mafia160

Also came through, then founded or led a company.

Ryan SheaBSEFounded Stacks Dario AmodeiPhDFounded Anthropic Fei-Fei LiBachelor of Arts - BAFounded World Labs Christian SchadeBachelor of Arts - BAFounded Halda Therapeutics +2 Emin Gun SirerB.S.E.Founded Avalanche +2 Luke EvninBachelor’s DegreeFounded Mpmcapital +1

+ 153 more

Harvard Medical School mafia28

Also came through, then founded or led a company.

Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3 Lyle BerkowitzMedical informatics sub-fellowshipFounded Apollo Health +1 Rushika FernandopulleM.D.Founded Iora Health Kevin BittermanPh.D.Founded Editas Medicine Jeffrey M. JonasMDFounded Sage Therapeutics

+ 22 more

5AM Ventures mafia4

Also came through, then founded or led a company.

Jamil BegPartnerFounded Nido Biosciences +1 Jonathan WeissmanVenture AdvisorFounded nChroma Bio Dr Arjun GoyalPrincipalFounded Affini-T Therapeutics

Same school

Also attended Harvard Medical School176

Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General Catalyst Anthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 170 more

Also attended Massachusetts Institute of Technology1,521

Fred WilsonCo-founder & Partner at Union Square Ventures Elad GilSolo general partner investing through Gil Capital Aileen LeeFounder & Managing Partner of Cowboy Ventures Hemant TanejaCEO & Managing Director of General Catalyst Nat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG Brad FeldCo-founder of Foundry and Techstars

+ 1,515 more

Also attended Harvard University1,885

Alfred LinPartner at Sequoia Capital Chris DixonFounder & Managing Partner of a16z crypto at Andreessen Horowitz Sarah TavelVenture Partner at Benchmark Danny RimerPartner at Index Ventures Laela SturdyManaging Partner at CapitalG Bill GatesCo-founder of Microsoft; Chair of the Gates Foundation

+ 1,879 more

Also attended Princeton University710

Fabrice GrindaCo-founder & Managing Partner at FJ Labs Ryan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of Anthropic Fei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at Stanford KJ SidberryInvestor at GV (Google Ventures)AndrewAdvisor at Clear Ventures

+ 704 more

Shared employers

Also worked at ProLynx3

Max FarinaPrincipal at 5AM Ventures Lauren DanielChief Compliance Officer and General Counsel at 5AM Ventures Sebastian BernalesGeneral Partner at Humboldt

Also worked at Princeton University110

Dario AmodeiCo-founder & CEO of Anthropic Fei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at Stanford Ryan HaysBoard Member at CincyTech Brad FloraBacking expeditions into the future Manny StockmanManaging Partner at Osage University Partners Brannon JonesPrincipal at AlleyCorp

+ 104 more

Also worked at Akouos1

Jamil BegPartner at 5AM Ventures

Also worked at Arvinas2

Briggs MorrisonEntrepreneur Partner at MPM BioImpact Jakob LovenPartner at Nextech Invest